PRDX3 and Miyoshi myopathy: The upregulated expression of Prdx3 is also observed in malignant mesothelioma (MM) cells and an overexpression of Prdx3 in MM cells maintains a redox set point that enables these cells to survive in conditions with elevated levels of mitochondrial ROS [169].